Skip to main content
logo
Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
26.20
-0.31 (-1.17%)
At close: Mar 3, 2026, 4:00 PM EST
26.50
+0.30 (1.15%)
Pre-market: Mar 4, 2026, 7:44 AM EST

Centessa Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
15-6.85---
Gross Profit
15-6.85---
Selling, General & Admin
50.1850.8153.7355.243.011.14
Research & Development
178.62150.24124.41155.0896.329.3
Operating Expenses
228.8201.06178.14210.28139.3310.44
Operating Income
-213.8-201.06-171.28-210.28-139.33-10.44
Interest Expense
-11.13-10.09-9.91-7.28-2.55-0.38
Interest & Investment Income
20.8814.0210.480.24--
Currency Exchange Gain (Loss)
-1.3-1.80.8-2.8-3.6-
Other Non Operating Income (Expenses)
0.140.11-0.33-0.76-0.770.16
EBT Excluding Unusual Items
-205.21-198.82-170.24-220.87-146.25-10.66
Other Unusual Items
-34.1-34.1-5.93.92-15.08-
Pretax Income
-239.31-232.91-176.14-216.95-381.79-10.66
Income Tax Expense
3.392.84-25.06-0.750.11-
Net Income
-242.7-235.76-151.09-216.21-381.9-10.66
Preferred Dividends & Other Adjustments
-----0.83-
Net Income to Common
-242.7-235.76-151.09-216.21-381.07-10.66
Shares Outstanding (Basic)
13311496937515
Shares Outstanding (Diluted)
13311496937515
Shares Change (YoY)
25.82%19.02%2.97%24.26%401.11%-
EPS (Basic)
-1.82-2.06-1.57-2.31-5.07-0.71
EPS (Diluted)
-1.82-2.06-1.57-2.31-5.07-0.71
Free Cash Flow
-181.17-142.09-160.51-201.68-136.34-10.63
Free Cash Flow Per Share
-1.36-1.24-1.67-2.16-1.81-0.71
Gross Margin
100.00%-100.00%---
Operating Margin
-1425.33%--2499.39%---
Profit Margin
-1617.99%--2204.66%---
Free Cash Flow Margin
-1207.80%--2342.20%---
EBITDA
-213.49-200.71-170.97-210.15-139.3-10.43
D&A For EBITDA
0.310.340.310.130.030.01
EBIT
-213.8-201.06-171.28-210.28-139.33-10.44
Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q